393. Kawahara S. Clinical evaluation of new quinolones as antituberculosis
drugs / S. Kawahara, A. Tada, H. Nagare // Kekkaku. - 1999. - Vol. 74, № 1. - P.
71-75.
394. Kienzle M.G. Clinical hemodynamic and sympathetic neural correlates
of heart rate variability in congestive heart failure / M.G. Kienzle, D.W. Fergusson,
C.L. Birkett // Am. J. Cardiol. - 1992. - Vol. 69. - P. 482-485.
395. Kitney R.G. Heart rate variability in the assessment of autonomic
diabetic neuropathy / R.I. Kitney, S. Byrne, M.L. Edmonds // Automedica. - 1982.
- № 4 . - P 155-167.
396. Kochi A. The global tuberculosis situation and the new control strategy
of the World Health Organization // Bull. WHO. - 2001. - Vol. 79, № 1. - P. 71-
75.
397. Kobashi Y. Clinical analysis of community-acquired pneumonia and
pulmonary tuberculosis in the eiderly and advances in treatment / Y. Kobashy, N.
Okimoti, T. Matsushima // Kekkeku. - 1998. - Vol. 73, № 7. - P. 485-490.
398. Konietzko N. Tuberculoses: Zuruk in die Vergangenheit? / N.
Konietzko // Atemwegs. Lungen Kr. - 1995. - Bd. 21, № 10. - S. 490-496.
399. Koumbanioniou Ch. Is pyrazinamide really the third drug of choice in
die treatment of tuberculosis / Ch. Koumbaniou / Int. J. Tuberc. And Lang Disease.
- 1998. - Vol. 2., № 8. - P. 675-678.
400. Kunin C.M. Antimicrobial activity of rifabutine / C.M. Kunin // Clin.
Infect. Dis. - 1996. - Vol. 22, suppl. 1. - P. 3-13.
401. Lille-back T. Molecular evidence of endogenous reactivation of M.
tuberculosis / T. Lille-back // Int. J. Tubercle Lung Dis. - 2001. - Vol. 5, № 1 1 .-
P 35.
402. Lubasch A. Sparfloxacin in the treatment of drug resistant tuberculosis
or intolerance of first line therapy / A. Lubasch, R. Erbes, H. Mauch et al. // Eur.
Respir. J . - 2001. - Vol. 17, № 4. - P. 641 -646.
399
